HI-TAC seeks Research Group Leaders in the field of CardioVascular Biology
The Helmholtz Institute for Translational AngioCardioScience (HI-TAC) is a branch of the Max Delbrück Center on the campus of Heidelberg University. The Max Delbrück Center and the Mannheim and Heidelberg Medical Faculties of the University of Heidelberg jointly founded HI-TAC. HI-TAC will develop a unique systemic approach in the emerging field of cardiovascular communication biology, which is operationally designated as AngioCardioScience. Translational research at HI-TAC aims at developing a new scientific program centered on communication biology and dedicated to understanding cardiovascular functions on a systemic level during homeostasis, aging and pathological conditions. It will exploit its findings in the area of cross-organ interactions for the development of translational applications.
HI-TAC is currently in the build up phase and will provide a modern place for 100 scientists to conduct research and work in Heidelberg and Mannheim. Join our team and build up the HI-TAC together with the Max Delbrück Center and the University of Heidelberg.
Establish your independent research group and help shape the future of AngioCardioScience.
We invite applications from outstanding early-career scientists with a strong scientific track record and a compelling vision for an independent research program that advances our understanding of cardiovascular biology. We particularly encourage innovative and interdisciplinary approaches, including perspectives from fields beyond traditional cardiovascular research.
Areas of particular interest include the cardiac microenvironment, cardiac/vascular metabolism and mechanobiology, cardiac/vascular-immune interactions and inflammatory pathways, cardiovascular malformations, inter-organ interactions, regeneration, and aging. We are especially interested in interdisciplinary approaches that explore how vascular and cardiac cells communicate with their surrounding tissues and contribute to physiological function, tissue homeostasis and disease.
HI-TAC operates at two sites: its Heidelberg location is based at the Institute of Experimental Cardiology, Heidelberg, and its Mannheim location is embedded in the biomedical research environment of University Medicine Mannheim. Non-tenured Group Leader positions are planned across these locations, offering the opportunity to establish independent research groups within a vibrant scientific and clinical research environment.
Workplace: HI-TAC Mannheim/Heidelberg
Salary: Remuneration will be in accordance with the TVöD Bund, depending on personal requirements, up to fee group 15.
Desired starting date: May 01, 2027
Limitation: Fixed Term. We offer funding for up to nine years, subject to midterm review after four years.
Team: Helmholtz Institute for Translational AngioCardioScience
Application Period: January 08, 2027
Employment volume: Full Time, 39 hours per week
Applications should be submitted via our online portal by January 8, 2027.
Selected candidates will be invited to attend an in-person scientific symposium on March 4, 2027.
For scientific inquiries regarding the positions, please contact the HI-TAC directors Prof. Dr. Karina Yaniv and Prof. Dr. Johannes Backs.
If you hold a foreign PhD or Master's degree, please submit proof of its recognition in Germany with your application. The recognition status can be verified via the anabin database, and the relevant documentation can be submitted as a PDF attachment.

Wissenschaftliche/r Mitarbeiter/in (m/w/d) molekulare Ursachen neurogenetischer Erkrankungen
Justus-Liebig-Universität Gießen · Gießen

Life Scientist (m/w/d)
TRON gGmbH · Mainz

PhD Candidate (f/m/d)
Karlsruher Institut für Technologie (KIT) Campus Nord · Eggenstein-Leopoldshafen

Wissenschaftliche Mitarbeiter*innen (m/w/d) in der Biochemie und Molekularmedizin zur Promotion (Dr. rer. nat.)
Universität Bielefeld · Bielefeld